Schein Subsidiary Marsam To Resume Manufacturing In Fourth Quarter

21 Jun 1999

• By The Pink Sheet

Schein subsidiary Marsam Pharmaceuticals expects to partially resume manufacturing by the end of 1999 after voluntarily suspending all manufacturing and testing at its Cherry Hill, N.J. facility.

Schein Subsidiary Marsam To Resume Manufacturing In Fourth Quarter

More from Archive

More from Pink Sheet